Dahlerup JF - Search Results

1

[Vitamin D insufficiency--possible etiologic factor of autoimmune diseases].

Jørgensen SP, Bartels LE, Agnholt J, Glerup H, Nielsen SL, Hvas CL, Dahlerup JF. Jørgensen SP, et al. Among authors: dahlerup jf. Ugeskr Laeger. 2007 Oct 22;169(43):3655-60. Ugeskr Laeger. 2007. PMID: 17967265 Review. Danish.

2

[Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography].

Keiding S, Hansen SB, Rasmussen HH, Gee A, Kruse A, Roelsgaard K, Tage-Jensen U, Dahlerup JF. Keiding S, et al. Among authors: dahlerup jf. Ugeskr Laeger. 2000 Feb 7;162(6):782-5. Ugeskr Laeger. 2000. PMID: 10689952 Danish.

3

Response, relapse and mucosal immune regulation after infliximab treatment in fistulating Crohn's disease.

Agnholt J, Dahlerup JF, Buntzen S, Tøttrup A, Nielsen SL, Lundorf E. Agnholt J, et al. Among authors: dahlerup jf. Aliment Pharmacol Ther. 2003 Mar 1;17(5):703-10. doi: 10.1046/j.1365-2036.2003.01487.x. Aliment Pharmacol Ther. 2003. PMID: 12641520 Free article.

4

[Pharmacologic treatment or endoscopic sclerotherapy as primary intervention for bleeding varices in cirrhotic patients].

Grønbaek H, Dahlerup JF, Vilstrup H. Grønbaek H, et al. Among authors: dahlerup jf. Ugeskr Laeger. 2003 Mar 10;165(11):1127-30. Ugeskr Laeger. 2003. PMID: 12677989 Danish. No abstract available.

5

T-cell vaccination in Crohn's disease: principles and presentation of the first two cases.

Agnholt J, Kaltoft K, Jakobsen NO, Dahlerup JF. Agnholt J, et al. Among authors: dahlerup jf. Cytokines Cell Mol Ther. 2002;7(3):117-23. doi: 10.1080/13684730310000130. Cytokines Cell Mol Ther. 2002. PMID: 12850811

6

The effect of etanercept and infliximab on the production of tumour necrosis factor alpha, interferon-gamma and GM-CSF in in vivo activated intestinal T lymphocyte cultures.

Agnholt J, Dahlerup JF, Kaltoft K. Agnholt J, et al. Among authors: dahlerup jf. Cytokine. 2003 Aug 7;23(3):76-85. doi: 10.1016/s1043-4666(03)00201-1. Cytokine. 2003. PMID: 12906870

7

Complement activation in plasma before and after infliximab treatment in Crohn disease.

Zimmermann-Nielsen E, Agnholt J, Thorlacius-Ussing O, Dahlerup JF, Baatrup G. Zimmermann-Nielsen E, et al. Among authors: dahlerup jf. Scand J Gastroenterol. 2003 Oct;38(10):1050-4. doi: 10.1080/00365520310005767. Scand J Gastroenterol. 2003. PMID: 14621279

8

Increased expression of TCR vbeta5.1 and 8 in mucosal T-cell lines cultured from patients with Crohn disease.

Kelsen J, Agnholt J, Hoffmann HJ, Kaltoft K, Dahlerup JF. Kelsen J, et al. Among authors: dahlerup jf. Scand J Gastroenterol. 2004 Mar;39(3):238-45. doi: 10.1080/00365520310008430. Scand J Gastroenterol. 2004. PMID: 15074393

9

Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease--a possible target for infliximab treatment.

Agnholt J, Kelsen J, Brandsborg B, Jakobsen NO, Dahlerup JF. Agnholt J, et al. Among authors: dahlerup jf. Eur J Gastroenterol Hepatol. 2004 Jul;16(7):649-55. doi: 10.1097/01.meg.0000108344.41221.8b. Eur J Gastroenterol Hepatol. 2004. PMID: 15201577

10

Indium-labelled human gut-derived T cells from healthy subjects with strong in vitro adhesion to MAdCAM-1 show no detectable homing to the gut in vivo.

Kelsen J, Agnholt J, Falborg L, Nielsen JT, Rømer JL, Hoffmann HJ, Dahlerup JF. Kelsen J, et al. Among authors: dahlerup jf. Clin Exp Immunol. 2004 Oct;138(1):66-74. doi: 10.1111/j.1365-2249.2004.02578.x. Clin Exp Immunol. 2004. PMID: 15373907 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters